These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 7589636)
21. Blood flow changes in the ovarian and uterine arteries in women with polycystic ovary syndrome who respond to clomiphene citrate: correlation with serum hormone concentrations. Zaidi J; Jacobs H; Campbell S; Tan SL Ultrasound Obstet Gynecol; 1998 Sep; 12(3):188-96. PubMed ID: 9793191 [TBL] [Abstract][Full Text] [Related]
22. Predictors for treatment failure after laparoscopic electrocautery of the ovaries in women with clomiphene citrate resistant polycystic ovary syndrome. van Wely M; Bayram N; van der Veen F; Bossuyt PM Hum Reprod; 2005 Apr; 20(4):900-5. PubMed ID: 15640254 [TBL] [Abstract][Full Text] [Related]
23. Metformin administration and laparoscopic ovarian drilling improve ovarian response to clomiphene citrate (CC) in oligo-anovulatory CC-resistant women with polycystic ovary syndrome. Palomba S; Orio F; Falbo A; Russo T; Caterina G; Manguso F; Tolino A; Colao A; Zullo F Clin Endocrinol (Oxf); 2005 Dec; 63(6):631-5. PubMed ID: 16343096 [TBL] [Abstract][Full Text] [Related]
24. Comparison of the effects of ovarian cauterization and gonadotropin-releasing hormone agonist and oral contraceptive therapy combination on endocrine changes in women with polycystic ovary disease. Taskin O; Yalcinoglu AI; Kafkasli A; Burak F; Ozekici U Fertil Steril; 1996 Jun; 65(6):1115-8. PubMed ID: 8641482 [TBL] [Abstract][Full Text] [Related]
25. The response of patients with polycystic ovarian disease to human menopausal gonadotropin therapy after ovarian electrocautery or a luteinizing hormone-releasing hormone agonist. Gadir AA; Alnaser HM; Mowafi RS; Shaw RW Fertil Steril; 1992 Feb; 57(2):309-13. PubMed ID: 1735480 [TBL] [Abstract][Full Text] [Related]
26. Extension of the clomiphene citrate stair-step protocol to gonadotropin treatment in women with clomiphene resistant polycystic ovarian syndrome. Horowitz E; Levran D; Weissman A Gynecol Endocrinol; 2017 Oct; 33(10):807-810. PubMed ID: 28454491 [TBL] [Abstract][Full Text] [Related]
27. A prospective randomized trial comparing the clinical and endocrinological outcome with rosiglitazone versus laparoscopic ovarian drilling in patients with polycystic ovarian disease resistant to ovulation induction with clomiphene citrate. Roy KK; Baruah J; Sharma A; Sharma JB; Kumar S; Kachava G; Karmakar D Arch Gynecol Obstet; 2010 May; 281(5):939-44. PubMed ID: 19956961 [TBL] [Abstract][Full Text] [Related]
28. A randomized controlled trial of the efficacy of rosiglitazone and clomiphene citrate versus metformin and clomiphene citrate in women with clomiphene citrate-resistant polycystic ovary syndrome. Rouzi AA; Ardawi MS Fertil Steril; 2006 Feb; 85(2):428-35. PubMed ID: 16595222 [TBL] [Abstract][Full Text] [Related]
29. Predictive value of serum androstenedione basal levels on the choice of gonadotropin or laparoscopic ovarian electrocautery as ovulation induction in clomiphene citrate-resistant patients with polycystic ovary syndrome. Vicino M; Loverro G; Bettocchi S; Simonetti S; Mei L; Selvaggi L Gynecol Endocrinol; 2000 Feb; 14(1):42-9. PubMed ID: 10813106 [TBL] [Abstract][Full Text] [Related]
30. Endocrine changes after laparoscopic ovarian drilling in clomiphene citrate-resistant women with polycystic ovarian syndrome. Al-Ojaimi EH Saudi Med J; 2004 Aug; 25(8):1032-9. PubMed ID: 15322594 [TBL] [Abstract][Full Text] [Related]
31. A prospective, double-blind, randomized, placebo-controlled clinical trial of bromocriptine in clomiphene-resistant patients with polycystic ovary syndrome and normal prolactin level. Parsanezhad ME; Alborzi S; Jahromi BN Int J Fertil Womens Med; 2002; 47(6):272-7. PubMed ID: 12570169 [TBL] [Abstract][Full Text] [Related]
33. Ovarian electrocautery versus human menopausal gonadotrophins and pure follicle stimulating hormone therapy in the treatment of patients with polycystic ovarian disease. Abdel Gadir A; Mowafi RS; Alnaser HM; Alrashid AH; Alonezi OM; Shaw RW Clin Endocrinol (Oxf); 1990 Nov; 33(5):585-92. PubMed ID: 2123759 [TBL] [Abstract][Full Text] [Related]
34. Does unilateral laparoscopic diathermy adjusted to ovarian volume increase the chances of ovulation in women with polycystic ovary syndrome? Sunj M; Canic T; Baldani DP; Tandara M; Jeroncic A; Palada I Hum Reprod; 2013 Sep; 28(9):2417-24. PubMed ID: 23820423 [TBL] [Abstract][Full Text] [Related]
35. Laparoscopic electrocautery of the ovaries versus recombinant FSH in clomiphene citrate-resistant polycystic ovary syndrome. Impact on women's health-related quality of life. van Wely M; Bayram N; Bossuyt PM; van der Veen F Hum Reprod; 2004 Oct; 19(10):2244-50. PubMed ID: 15242999 [TBL] [Abstract][Full Text] [Related]
37. Prognostic value of total testosterone for pregnancy during treatment in patients with clomiphene-citrate-resistant polycystic ovary syndrome: a pilot study. Li C; Cheng J; Wang J; Xue Y; Huang Z; Zhang S; Lv J Arch Gynecol Obstet; 2011 Sep; 284(3):757-64. PubMed ID: 21614496 [TBL] [Abstract][Full Text] [Related]
38. Hypothalamic-pituitary-ovarian response to clomiphene citrate in women with polycystic ovary syndrome. Kettel LM; Roseff SJ; Berga SL; Mortola JF; Yen SS Fertil Steril; 1993 Mar; 59(3):532-8. PubMed ID: 8458453 [TBL] [Abstract][Full Text] [Related]
39. Review of nonsurgical and surgical treatment and the role of insulin-sensitizing agents in the management of infertile women with polycystic ovary syndrome. Saleh AM; Khalil HS Acta Obstet Gynecol Scand; 2004 Jul; 83(7):614-21. PubMed ID: 15225184 [TBL] [Abstract][Full Text] [Related]
40. Endocrine effects of laparoscopic ovarian electrocautery in patients with polycystic ovarian disease, resistant to clomiphene citrate. van der Weiden RM; Alberda AT; de Jong FH; Brandenburg H Eur J Obstet Gynecol Reprod Biol; 1989 Aug; 32(2):157-62. PubMed ID: 2528489 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]